Comparative studies on effects of all-trans-retinoic acid and all-trans-retinoyl-β-D-glucuronide on the development of foetal mouse thymus in an organ culture system

Toxicology in Vitro

Volumn 10, Issue 1, 1996, Pages 7-15

  Foerster, M ^a   Sass, J O ^a   Ruhl R ^a   Nau, H ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID; RETINOIC ACID GLUCURONIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FETOTOXICITY; FETUS; MOUSE; NONHUMAN; ORGAN CULTURE; ORGANOGENESIS; THYMOCYTE; THYMUS; ULTRASTRUCTURE;

EID: 0030009577     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/0887-2333(95)00094-1     Document Type: Article

References (45)

1. 3H]retinoyl-β-D-glucuronide and its metabolism in rats in vivo. Biochemical Journal 263, 403-409.
2. Bockman D. R. and Kirby M. L. (1984) Dependence of thymus development on derivatives of the neural crest. Science 233, 498-500.
3. Bollag W. (1985) New retinoids with potential use in humans. In Retinoids: New Trends in Research and Therapy. Retinoid Symposium, Geneva 1984. Edited by J. H. Saurat. pp. 274-288. Karger, Basel.
4. Creech-Kraft J., Bechter R., Lee Q. P. and Juchau M. J. (1992) Microinjection of cultured rat conceptus: studies with 4-oxo-all-trans-retinoic acid, 4-oxo-13-cis-retinoic acid and all-trans-retinoyl-β-glucuronide. Teratology 45, 259-270.
5. Creech-Kraft J., Eckhoff C., Kochhar D. M., Bochert G., Chahoud I. and Nau H. (1991) Isotretinoin (13-cis-retinoic acid) metabolism, cis-trans isomerization, glucuronidation and transfer to the mouse embryo: consequences for teratogenicity. Teratogenesis, Carcinogenesis and Mutagenesis 11, 21-30.
6. Creech-Kraft J., Löfberg B., Chahoud I., Bochert G. and Nau H. (1989) Teratogenicity and placental transfer of all-trans-, 13-cis, 4-oxo-all-trans-, and 4-oxo-13-cis-retinoic acid after administration of a low oral dose during organogenesis in mice. Toxicology and Applied Pharmacology 100, 162-176.
7. Collins M. D., Eckhoff C., Chahoud I., Bochert G. and Nau H. (1992) 4-Methylpyrazole partially ameliorated the teratogenicity of retinol and reduced the metabolic formation of all-trans retinoic acid in the mouse. Archives of Toxicology 66, 652-659.
8. Collins M. D., Tzimas G., Hummler H., Bürgin H. and Nau H. (1994) Comparative teratology and pharmacokinetics of all-trans-retinoic acid, 13-cis-retinoic acid and retinyl palmitate in the rat following daily administration of equipotent teratogenic doses. Toxicology and Applied Pharmacology 127, 132-144.
9. d'Argy R., Berman J. and Dencker L. (1989) Effects of immunosuppressive chemicals on lymphoid development in foetal thymus organ cultures. Pharmacology and Toxicology 64, 33-38.
10. Davis C. Y. and Sell J. L. (1983) Effect of all-trans retinol and retinoic acid nutriture on the immune system of chicks. Journal of Nutrition 113, 1914-1919.
11. Dollé P., Ruberte E., Leroy P., Gillian M. K. and Chambon P. (1990) Retinoic acid receptors and cellular retinoid binding proteins. Development 110, 1133-1151.
12. Dillehay D. L., Li W., Kalin J., Walia A. S. and Lamon E. W. (1987) In vitro effects of retinoids on thymus-dependent and thymus-independent mitogenesis. Cellular Immunology 107, 130-137.
13. Eckhoff C. and Nau H. (1990) Identification and quantification of a-trans- and 13-cis-retinoic acid and 13-cis-4-oxoretinoic acid in human plasma. Journal of Lipid Research 31, 1445-1454.
14. Favennec L. and Gals M. J. (1988) The biological effects of retinoids on cell differentiation and proliferation. Journal of Clinical Chemistry and Clinical Biochemistry 26, 479-489.
15. Fernhoff P. M. and Lammer E. J. (1984) Craniofacial features of isotretinoin embryopathy. Journal of Pediatrics 105, 595-597.
16. Foerster M., Kastner U. and Neubert R. (1992) Effect of six virustatic nucleoside analogues on the development of fetal rat thymus in organ culture. Archives of Toxicology 66, 688-699.
17. Gallup J. M., Barua A. B., Furr H. C. and Olson J. A. (1987) Effects of retinoid β-glucuronides and N-retinoyl amines on the differentiation of HL-60 cells in vitro. Proceedings of the Society of Experimental Biology and Medicine 186, 269-274.
18. Gunning D. B., Barua A. B. and Olson J. A. (1993) Comparative teratology and metabolism of all-trans-retinoic acid, all-trans retinoyl β-glucose, and all-trans retinoyl β-glucuronide in pregnant Sprague-Dawley rats. Teratology 47, 29-36.
19. Heyman R. A., Mangelsdorf D. J., Dyck J. A., Stein R. B., Eichele G., Evans R. M. and Thaller C. (1992) 9-cis-Retinoic acid is a high affinity ligant for the retinoid X receptor. Cell 68, 397-406.
20. Holland D. B., Gowland G. and Cunliffe W. J. (1984) Inflammatory responses in acne patients treated with 13-cis-retinoic acid (isotretinoin). British Journal of Dermatology 110, 343-345.
21. Iwata M., Mukai M., Nakai Y. and Iseki R. (1992) Retinoic acids inhibit activation-induced apoptosis in T-cell hybridomas and thymocytes. Journal of Immunology 149, 3302-3308.
22. Janick-Buckner D., Barua A. B. and Olson J. A. (1992) Induction of HL-60 cell differentiation by water-soluble and nitrogen-containing conjugates of retinoic acid and retinol. FASEB Journal 5, 320-325.
23. 3H]retinoic acid (vitamin A acid) to pregnant mice. Teratology 14, 53-64.
24. Lammer E. J., Chen D. T., Hoar R. M., Agnish N. D., Benke P. J., Braun J. T., Curry C. J., Fernhoff P. M., Grix A. W., Lott I. T., Richard J, M. and Sun S. C. (1985) Retinoic acid embryopathy. New England Journal of Medicine 313, 837-841.
25. Lotan R. and Lotan D. (1981) Enhancement of melanotic expression in cultured mouse melanoma cells by retinoids. Journal of Cellular Physiology 106, 179-189.
26. Maden M., Ong D. E., Summerbell D. and Chytil F. (1989) The role of retinoid-binding proteins in the generation of pattern in the developing limb, the regenerating limb, and the nervous system. Development 107 (suppl.), 109-119.
27. Matsushima Y., Kawachi E., Tanaka H., Kagechika H., Hashimoto Y. and Shudo K. (1993) Differentiation-inducing activity of retinoic acid isomers and their oxidized analogs on human promyelocytic leukemia HL-60 cells. Biochemical and Biophysical Research Communications 189, 1136-1142.
28. Medawar P. B. and Hunt R. (1981) Anti-cancer action of retinoids. Immunology 42, 349-352.
29. Mehta R. G., Barua A. B., Olson J. A. and Moon R. C. (1992) Retinoid glucuronides do not interact with retinoic binding proteins. International Journal of Nutrition Research 62, 143-147.
30. Mendelsohn C., Ruberte E. and Chambony P. (1992) Retinoid receptors in vertebrate limb development. Developmental Biology 152, 50-61.
31. Morriss G. M. (1976) Abnormal cell migration as a possible factor in the genesis of vitamin A-induced craniofacial abnormalities. In New Approaches to the Evaluation of Abnormal Embryonic Development. Edited by D. Neubert and H. J. Merker, pp. 678-687. Thieme, Stuttgart.
32. Ozawa K., Sato N., Urabe A. and Takaku F. (1984) Modulation of normal myelopoiesis in vitro by retinoic acid. Biochemical and Biophysical Research Communications 123, 128-132.
33. Robinson J. M. and Jordan R. R. (1983) Thymus in vitro. Immunology Today 4, 41-44.
34. Rosa F. W., Wilk A. L. and Kelsey F. O. (1986) Teratogen update: vitamin A congeners. Teratology 33, 355-364.
35. Ruberte E., Dollé P., Chambon P. and Morriss-Kay G. (1991) Retinoic acid receptors and cellular retinoid binding proteins. II. Their differential pattern of transcription during early morphogenesis in mouse embryos. Development 111, 45-60.
36. Sakashita A., Kizaki M., Pakkala S., Schiller G., Tsuruoka N., Tomosaki R., Cameron J. F., Dawson M. I. and Koeffler H. P. (1993) 9-cis-Retinoic acid: effects on normal and leukemic hematopoiesis in vitro. Blood 81, 1009-1016.
37. Sass J. O., Tzimas G. and Nau H. (1994) 9-cis-retinoyl-β-D-glucuronide is a major metabolite of 9-cis-retinoic acid. Life Sciences 54, 69-74.
38. Sani B. P., Barua A. B., Hill D. L., Shih T. W. and Olson J. A. (1992) Retinoyl beta-glucuronide: lack of binding to receptor proteins of retinoic acid as related to biological activity. Biochemical Pharmacology 43, 919-922.
39. Seifter E., Rettura G., Stratford F., Yee C., Weinzweig J., Jacobson N. L. and Levenson S. M. (1981) Vitamin A inhibits some aspects of systemic disease due to local x-radiation. Journal of Parenteral and Enteral Nutrition 5, 288-294.
40. Smith M. A., Parkinson D. R., Cheson B. D. and Friedman M. A. (1992) Retinoids in cancer therapy. Journal of Clinical Oncology 10, 839-864.
41. Sidell N., Chang B. and Bhatti L. (1993) Upregulation by retinoic acid of interleukin-2-receptor mRNA in human T lymphocytes. Cellular Imunology 146, 28-37.
42. Shapiro P. E. and Edelson R. L. (1985) Effects of retinoids on the immune system. In Retinoids: New Trends in Research and Therapy. Retinoid Symposium, Geneva 1984. Edited by J. H. Saurat. pp. 225-235. Karger, Basel.
43. Tsambaos D. and Zimmermann B. (1991) Effects of synthetic retinoids on cellular systems. In Psoriasis. Edited by H. H. Roenigk and H. I. Maibach. pp. 659-707. Marcel Dekker, New York.
44. Tzimas G., Bürgin H., Collins M. D., Hummler H. and Nau H. (1994) The high sensitivity of the rabbit to the teratogenic effects of 13-cis-retinoic acid is a consequence of prolonged exposure of the embryo to 13-cis-retinoic acid and 13-cis-4-oxo-retinoic acid, and not to all-trans-retinoic acid. Archives of Toxicology 68, 119-128.
45. Zile M. H., Cullum M. E., Simpson R. U., Barua A. B. and Swartz D. A. (1987) Induction of differentiation of human promyelocytic leukemia cell line HL-60 by retinoyl glucuronide, a biologically active metabolite of vitamin A. Proceedings of the National Academy of Science of the U.S.A. 84, 2208-2212.